GSK files for extended use of Relvar Ellipta in asthma

24th July 2017 Uncategorised 0

GlaxoSmithKline and Innoviva have applied to market Relvar Ellipta for extended use in patients with asthma who are already adequately controlled on inhaled corticosteroid (ICS)/long-acting β2-agonist (LABA) therapy.

More: GSK files for extended use of Relvar Ellipta in asthma
Source: News